NEPHROS INC 4
4 · NEPHROS INC · Filed Sep 11, 2015
Insider Transaction Report
Form 4
NEPHROS INCNEPH
CENTELLA LAWRENCE J
Director
Transactions
- Award
Common Stock
2015-09-09+97,135→ 218,467 total
Holdings
- 1,000
Stock Option (Right to Buy)
Exercise: $19.00Exp: 2020-01-08→ Common Stock (1,000 underlying) - 60,000
Stock Option (Right to Buy)
Exercise: $0.51Exp: 2021-03-24→ Common Stock (60,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $0.83Exp: 2022-02-16→ Common Stock (10,000 underlying) - 500
Stock Option (Right to Buy)
Exercise: $51.40Exp: 2016-02-02→ Common Stock (500 underlying) - 500
Stock Option (Right to Buy)
Exercise: $26.80Exp: 2017-05-02→ Common Stock (500 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $0.71Exp: 2023-05-23→ Common Stock (10,000 underlying) - 26,598
Stock Option (Right to Buy)
Exercise: $0.46Exp: 2024-03-26→ Common Stock (26,598 underlying)
Footnotes (3)
- [F1]On September 9, 2015, the Company granted 97,135 shares of restricted stock of the Company (the "Restricted Stock") in respect of the service by Mr. Centella as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests 6 months following the grant date.
- [F2]100% vested.
- [F3]Vests as to 8,866 shares on each of 3/26/14, 3/26/15 and 3/26/16.